Literature DB >> 14573799

Identification of cis-acting sequences required for selective packaging of bovine adenovirus type 3 DNA.

Li Xing1, Linong Zhang1, Jill Van Kessel1, Suresh Kumar Tikoo1.   

Abstract

The assembly of adenovirus particles is a multistep process, in which viral genomic DNA is selected and subsequently inserted into preformed empty capsids. The selective encapsidation of the adenovirus genome is directed by cis-acting packaging motifs, termed A repeats due to their AT-rich character in DNA sequence. A repeats are usually located at the left end of the viral genome. In this report, the construction and analysis of bovine adenovirus type 3 (BAdV-3) mutants containing deletion mutations introduced into the AT-rich regions are described. The main cis-acting packaging domains of BAdV-3 were localized between nt 224 and 540 relative to the left end of the viral genome. They displayed a functional redundancy and followed a hierarchy of importance. In addition, the results demonstrated that not all of the AT-rich units functioned as cis-acting packaging motifs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14573799     DOI: 10.1099/vir.0.19418-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

1.  Nuclear and Nucleolar Localization of Bovine Adenovirus-3 Protein V.

Authors:  Xin Zhao; Suresh K Tikoo
Journal:  Front Microbiol       Date:  2021-01-06       Impact factor: 5.640

2.  First step in characterization of cis-acting sequences involved in fowl adenovirus 1 (CELO) packaging and its effect on the development of a helper-dependent vector strategy.

Authors:  Claire Barra; Patrick Langlois
Journal:  Virus Genes       Date:  2008-09-30       Impact factor: 2.332

Review 3.  Development of nonhuman adenoviruses as vaccine vectors.

Authors:  Dinesh S Bangari; Suresh K Mittal
Journal:  Vaccine       Date:  2005-09-23       Impact factor: 3.641

Review 4.  Bovine adenovirus-3 as a vaccine delivery vehicle.

Authors:  Lisanework E Ayalew; Pankaj Kumar; Amit Gaba; Niraj Makadiya; Suresh K Tikoo
Journal:  Vaccine       Date:  2014-12-09       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.